Annual Operating Profit
-$46.08 M
+$18.77 M+28.95%
31 December 2023
Summary:
Akebia Therapeutics annual operaing income is currently -$46.08 million, with the most recent change of +$18.77 million (+28.95%) on 31 December 2023. During the last 3 years, it has risen by +$331.75 million (+87.81%). AKBA annual operating profit is now -440.60% below its all-time high of -$8.52 million, reached on 31 December 2012.AKBA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$12.51 M
-$3.78 M-43.32%
30 September 2024
Summary:
Akebia Therapeutics quarterly operating income is currently -$12.51 million, with the most recent change of -$3.78 million (-43.32%) on 30 September 2024. Over the past year, it has increased by +$362.00 thousand (+2.81%). AKBA quarterly operating profit is now -125.73% below its all-time high of $48.61 million, reached on 30 June 2022.AKBA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$34.73 M
+$362.00 K+1.03%
30 September 2024
Summary:
Akebia Therapeutics TTM operating income is currently -$34.73 million, with the most recent change of +$362.00 thousand (+1.03%) on 30 September 2024. Over the past year, it has increased by +$16.36 million (+32.02%). AKBA TTM operating profit is now -1248.00% below its all-time high of -$2.58 million, reached on 31 March 2013.AKBA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.9% | +2.8% | +32.0% |
| 3 y3 years | +87.8% | +77.2% | +87.8% |
| 5 y5 years | +74.1% | +77.6% | +87.7% |
AKBA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +87.8% | -125.7% | +80.9% | -12.9% | +87.8% |
| 5 y | 5 years | at high | +87.8% | -125.7% | +92.8% | -12.9% | +91.0% |
| alltime | all time | -440.6% | +87.8% | -125.7% | +92.8% | -1248.0% | +91.0% |
Akebia Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.51 M(+43.3%) | -$34.73 M(-1.0%) |
| June 2024 | - | -$8.72 M(-41.4%) | -$35.10 M(-1.0%) |
| Mar 2024 | - | -$14.88 M(-1182.8%) | -$35.46 M(-23.0%) |
| Dec 2023 | -$46.08 M(-28.9%) | $1.37 M(-110.7%) | -$46.07 M(-9.8%) |
| Sept 2023 | - | -$12.87 M(+41.6%) | -$51.09 M(-42.2%) |
| June 2023 | - | -$9.09 M(-64.3%) | -$88.45 M(+187.6%) |
| Mar 2023 | - | -$25.49 M(+599.0%) | -$30.76 M(-51.8%) |
| Dec 2022 | -$64.85 M(-75.5%) | -$3.65 M(-92.7%) | -$63.76 M(-49.2%) |
| Sept 2022 | - | -$50.23 M(-203.3%) | -$125.45 M(-3.6%) |
| June 2022 | - | $48.61 M(-183.1%) | -$130.11 M(-49.6%) |
| Mar 2022 | - | -$58.49 M(-10.5%) | -$258.06 M(-2.4%) |
| Dec 2021 | -$264.50 M(-30.0%) | -$65.34 M(+19.0%) | -$264.50 M(-7.5%) |
| Sept 2021 | - | -$54.89 M(-30.8%) | -$285.95 M(-1.1%) |
| June 2021 | - | -$79.34 M(+22.2%) | -$289.16 M(-24.6%) |
| Mar 2021 | - | -$64.94 M(-25.2%) | -$383.64 M(+1.5%) |
| Dec 2020 | -$377.83 M(+32.0%) | -$86.79 M(+49.4%) | -$377.83 M(-2.1%) |
| Sept 2020 | - | -$58.09 M(-66.6%) | -$385.93 M(+0.6%) |
| June 2020 | - | -$173.82 M(+194.0%) | -$383.74 M(+42.4%) |
| Mar 2020 | - | -$59.13 M(-37.7%) | -$269.44 M(-5.9%) |
| Dec 2019 | -$286.29 M(+60.7%) | -$94.89 M(+69.7%) | -$286.29 M(+1.7%) |
| Sept 2019 | - | -$55.91 M(-6.1%) | -$281.56 M(+11.1%) |
| June 2019 | - | -$59.52 M(-21.6%) | -$253.49 M(+10.4%) |
| Mar 2019 | - | -$75.97 M(-15.7%) | -$229.63 M(+28.9%) |
| Dec 2018 | -$178.16 M | -$90.16 M(+223.8%) | -$178.16 M(+142.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$27.84 M(-21.9%) | -$73.39 M(+5.3%) |
| June 2018 | - | -$35.66 M(+45.6%) | -$69.73 M(+24.1%) |
| Mar 2018 | - | -$24.50 M(-267.7%) | -$56.20 M(-26.7%) |
| Dec 2017 | -$76.67 M(-43.8%) | $14.61 M(-160.4%) | -$76.67 M(-40.7%) |
| Sept 2017 | - | -$24.18 M(+9.2%) | -$129.33 M(-8.5%) |
| June 2017 | - | -$22.14 M(-50.8%) | -$141.33 M(-9.0%) |
| Mar 2017 | - | -$44.97 M(+18.2%) | -$155.39 M(+13.9%) |
| Dec 2016 | -$136.46 M(+121.8%) | -$38.04 M(+5.1%) | -$136.46 M(+15.2%) |
| Sept 2016 | - | -$36.18 M(-0.0%) | -$118.47 M(+16.2%) |
| June 2016 | - | -$36.19 M(+38.9%) | -$101.96 M(+33.0%) |
| Mar 2016 | - | -$26.05 M(+29.9%) | -$76.66 M(+24.6%) |
| Dec 2015 | -$61.51 M(+62.1%) | -$20.05 M(+1.9%) | -$61.51 M(+18.1%) |
| Sept 2015 | - | -$19.68 M(+80.7%) | -$52.07 M(+24.0%) |
| June 2015 | - | -$10.89 M(-0.1%) | -$41.98 M(+7.8%) |
| Mar 2015 | - | -$10.90 M(+2.7%) | -$38.93 M(+2.6%) |
| Dec 2014 | -$37.94 M(+138.1%) | -$10.61 M(+10.7%) | -$37.94 M(+13.1%) |
| Sept 2014 | - | -$9.58 M(+22.2%) | -$33.53 M(+19.8%) |
| June 2014 | - | -$7.84 M(-20.9%) | -$27.98 M(+20.3%) |
| Mar 2014 | - | -$9.91 M(+59.8%) | -$23.26 M(+46.0%) |
| Dec 2013 | -$15.93 M(+86.9%) | -$6.20 M(+53.7%) | -$15.93 M(+63.7%) |
| Sept 2013 | - | -$4.03 M(+29.3%) | -$9.73 M(+70.8%) |
| June 2013 | - | -$3.12 M(+21.1%) | -$5.70 M(+121.1%) |
| Mar 2013 | - | -$2.58 M | -$2.58 M |
| Dec 2012 | -$8.52 M | - | - |
FAQ
- What is Akebia Therapeutics annual operaing income?
- What is the all time high annual operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics annual operating profit year-on-year change?
- What is Akebia Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly operating profit year-on-year change?
- What is Akebia Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Akebia Therapeutics?
- What is Akebia Therapeutics TTM operating profit year-on-year change?
What is Akebia Therapeutics annual operaing income?
The current annual operating profit of AKBA is -$46.08 M
What is the all time high annual operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high annual operaing income is -$8.52 M
What is Akebia Therapeutics annual operating profit year-on-year change?
Over the past year, AKBA annual operaing income has changed by +$18.77 M (+28.95%)
What is Akebia Therapeutics quarterly operating income?
The current quarterly operating profit of AKBA is -$12.51 M
What is the all time high quarterly operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly operating income is $48.61 M
What is Akebia Therapeutics quarterly operating profit year-on-year change?
Over the past year, AKBA quarterly operating income has changed by +$362.00 K (+2.81%)
What is Akebia Therapeutics TTM operating income?
The current TTM operating profit of AKBA is -$34.73 M
What is the all time high TTM operating profit for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM operating income is -$2.58 M
What is Akebia Therapeutics TTM operating profit year-on-year change?
Over the past year, AKBA TTM operating income has changed by +$16.36 M (+32.02%)